DYNAMICURE Trademark

Pharmaceutical preparations for the treatment of oncological diseases and disorders; Pharmaceutical preparations for the treatment of autoimmune diseases and disorders, autoimmune deficiency; Pharmaceutical preparations for the treatment of genetic disorders; Pharmaceutical preparations for the treatment of metabolic diseases; Pharmaceutical preparations for the treatment of neurodegenerative diseases; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for the treatment of eye diseases; Pharmaceutical preparations for the treatment of cardiovascular diseases; Diagnostic biomarker reagents for medical purposes; Protein arrays for medical diagnosis purposes; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Diagnostic preparations for medical purposes; Pharmaceutical preparations for the treatment of oncological diseases and disorders, autoimmune diseases and disorders, autoimmune deficiency, genetic disorders, metabolic diseases, neurodegenerative diseases, kidney diseases, eye diseases, cardiovascular diseases, all of the foregoing excluding treatments and diagnostics for neuromuscular disorders and orphan diseases

Pharmaceutical research and development; Research and development in the field of biologics, namely, antibodies and peptides for the field of cancer, immunotherapies, autoimmune diseases, autoimmune disorders, genetic disorders, metabolic diseases, neurodegenerative diseases, kidney diseases, eye diseases, and cardiovascular diseases; Research and development in the field of pharmaceuticals, biopharmaceuticals, and biotechnologies for the treatment of cancer, immunotherapies, autoimmune diseases, autoimmune disorders, genetic disorders, metabolic diseases, neurodegenerative diseases, kidney diseases, eye diseases, and cardiovascular diseases; Research and development in the field of biotechnology; Research and development in the field of laboratory testing, diagnostics, and pharmacogenetics for the treatment of cancer, immunotherapies, autoimmune diseases, autoimmune disorders, genetic disorders, metabolic diseases, neurodegenerative diseases, kidney diseases eye diseases, and cardiovascular diseases; Providing medical and scientific research information; Providing medical and scientific research information in the field of pharmaceutical research and development, biotechnology, and pharmacogenetics with respect to cancer, immunotherapies, autoimmune diseases, autoimmune disorders, genetic disorders, metabolic diseases, neurodegenerative diseases, kidney diseases eye diseases, and cardiovascular diseases; Consulting services in the field of pharmaceutical research and development; Consulting services in the field of biotechnology; Consulting services in the field of pharmacogenetics; Consulting services in the field of pharmaceutical research and development, biotechnology, and pharmacogenetics with respect to cancer, immunotherapies, autoimmune diseases, autoimmune disorders, genetic disorders, metabolic diseases, neurodegenerative diseases, kidney diseases eye diseases, and cardiovascular diseases; Research and development in the fields of oncological diseases and disorders, autoimmune diseases and disorders, autoimmune deficiency, genetic disorders, metabolic diseases, neurodegenerative diseases, kidney diseases, eye diseases, cardiovascular diseases, all the foregoing excluding treatments and diagnostics for neuromuscular disorders and orphan diseases